Stories to Prevent (StoP) HPV Cancers
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMilton S. Hershey Medical Center
About this trial
This randomized controlled trial (RCT) evaluates the association of a narrative communication intervention on human papillomavirus (HPV) vaccination rates among 9- to 12-year-olds. The intervention is a brief video from local cancer survivors narrating their stories with an HPV-related cancer diagnosis and recommending the HPV vaccine for cancer prevention. RCT participants will be the parents (n=200) of children ages 9-12 who have not initiated HPV vaccination. Participants will be randomized (1:1) to our intervention or control (placebo video) one week before their child's next primary care visit. Our primary outcome is HPV vaccine initiation (first dose of the HPV vaccine series) among children ages 9-12 at the time of the wellness visit. The study also explores the effect of narratives on theory-based mediators of HPV vaccination, including parents' cognitive (e.g., risk perception) and emotional reactions (e.g., hope, anticipated regret).
Eligibility criteria
Qualifiers
Parent/guardian of a 9-12 year old receiving primary care at a Penn State Health clinic
Their child has not previously received or initiated the HPV vaccine
Is able to read and understand spoken English or Spanish
Has a valid email address and access to a mobile phone, table, desktop or laptop computer to engage in the intervention
Disqualifiers
Parent of guardian is less than 18 years of age
Unable to read and understand spoken English or Spanish
Does not have access to a mobile phone, table, desktop or laptop computer
Trial design
Treatments tested in this trial
- Cancer survivor narrative
- Healthy eating tips
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov